Olema Pharmaceuticals, Inc. (OLMA)
12.90
-0.64
(-4.76%)
USD |
NASDAQ |
May 27, 16:00
13.07
+0.16
(+1.28%)
After-Hours: 17:39
Olema Pharmaceuticals Cash from Investing (Quarterly) : 4.529M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | -192.78M |
| Protagonist Therapeutics, Inc. | 90.89M |
| Cogent Biosciences, Inc. | -36.46M |
| Disc Medicine, Inc. | 58.31M |
| Nuvalent, Inc. | -19.41M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -45.99M |
| Cash from Financing (Quarterly) | 45.70M |
| Free Cash Flow | -148.72M |
| Free Cash Flow Per Share (Quarterly) | -0.4473 |
| Free Cash Flow to Equity (Quarterly) | -45.75M |
| Free Cash Flow to Firm (Quarterly) | -45.99M |
| Free Cash Flow Yield | -12.62% |